Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (IP.2007.3110.001)
European Community's Seventh Framework Programme (N° 242095 (EVIMALAR))
Received: 17 July 2020
Accepted: 19 November 2020
First Online: 26 November 2020
Ethics approval and consent to participate
: The clinical study and all study protocols were approved by the School of Medicine Research and Ethics Committee of the College of Health Sciences, Makerere University and by the Uganda National Council for Science and Technology (approval number HS 765). All participants provided written informed consent. All children received appropriate treatment for other attendant medical conditions.
: Not applicable.
: The authors declare that they have no competing interests.